Effective Strategies for Managing Opioid Use Disorder

The Complexity of Opioid Use Disorder Model

Understanding OUD necessitates a multi-faceted approach due to its complexity. The Complexity of Opioid Use Disorder Model (COUDM) integrates various dimensions of OUD, including coexisting symptoms such as chronic pain, anxiety, and nicotine dependence. The model proposes that these interconnected issues exacerbate the severity of OUD and require comprehensive treatment strategies (Coffee et al., 2025).

Overview of COUDM

1. Biopsychosocial Factors: This framework acknowledges that OUD is influenced by biological, psychological, and social elements. Factors such as genetics, environment, and individual life experiences shape the disorder (Coffee et al., 2025).

2. Symptom Clusters: OUD often coexists with other symptoms, notably chronic pain (CP) and anxiety. Individuals with OUD frequently experience these comorbidities, which complicate treatment and recovery (Coffee et al., 2025).

3. Integrative Approaches: The model emphasizes the need for integrative therapies, such as Tai Chi Easy (TCE), which can address multiple symptoms concurrently, promoting overall well-being (Coffee et al., 2025).

Coexisting Symptoms: Pain, Anxiety, and Nicotine Dependence

Individuals with OUD often present with additional challenges that hinder recovery:

• Chronic Pain: Approximately 55% to 61% of individuals with OUD experience chronic pain, complicating their treatment and increasing reliance on opioids (Coffee et al., 2025).

• Anxiety: There is a significant correlation between anxiety disorders and OUD. About 60% of people with OUD have a history of anxiety disorders, which can worsen treatment outcomes (Coffee et al., 2025).

• Nicotine Dependence: High rates of smoking are observed in individuals with OUD, with studies indicating that 84% to 94% of individuals with OUD also smoke. This dual dependence can further complicate treatment and recovery (Coffee et al., 2025).

Role of Non-Pharmacological Therapies in OUD Management

Integrative therapies, particularly mind-body approaches, are gaining recognition in the management of OUD.

Tai Chi Easy (TCE)

TCE is an accessible, holistic intervention that combines gentle movement, breath control, and meditative practices. Research indicates that TCE can effectively reduce symptoms associated with OUD, including CP and anxiety, while enhancing overall self-care (Coffee et al., 2025).

Benefits of Non-Pharmacological Approaches

• Reduced Reliance on Opioids: Mind-body therapies can decrease the need for pharmacological interventions and mitigate withdrawal symptoms.
• Improved Mental Health: These therapies promote relaxation and stress reduction, which can alleviate anxiety and improve quality of life for individuals with OUD.

Impact of Self-Determination Theory on Treatment Engagement

Self-Determination Theory (SDT) plays a crucial role in enhancing treatment engagement among individuals with OUD. The theory posits that fulfilling three basic psychological needs—autonomy, competence, and relatedness—can foster intrinsic motivation, leading to better treatment outcomes (Coffee et al., 2025).

Application of SDT in OUD Management

• Autonomy: Empowering individuals to make informed choices about their treatment can enhance their commitment to recovery.
• Competence: Providing skills and education about managing OUD can foster a sense of achievement and self-efficacy.
• Relatedness: Building supportive relationships within treatment settings can improve engagement and reduce feelings of isolation.

Future Directions in Opioid Use Disorder Research and Treatment

OUD management is evolving, with ongoing research aimed at enhancing treatment effectiveness and patient outcomes. Future directions include:

• Holistic Framework Development: Continued refinement of the COUDM to incorporate emerging research findings and adapt to the needs of diverse patient populations (Coffee et al., 2025).
• Innovative Interventions: Exploring the efficacy of novel therapies and integrating them into comprehensive treatment plans.
• Focus on Prevention: Developing preventative measures to address the root causes of OUD and reduce the incidence of new cases.

Conclusion

The management of Opioid Use Disorder requires a comprehensive understanding of its complexity and the interplay of coexisting symptoms. By adopting holistic frameworks that consider the biopsychosocial aspects of health, utilizing non-pharmacological therapies, and applying principles from Self-Determination Theory, healthcare providers can enhance treatment engagement and improve outcomes for individuals suffering from OUD.

FAQ

What is Opioid Use Disorder (OUD)? OUD is a chronic condition characterized by the compulsive use of opioids, despite harmful consequences. It often coexists with other mental health and physical conditions, complicating treatment.

How do coexisting symptoms affect OUD? Coexisting symptoms such as chronic pain, anxiety, and nicotine dependence can exacerbate OUD, making it more difficult for individuals to engage in treatment and achieve recovery.

What role do non-pharmacological therapies play in OUD management? Non-pharmacological therapies, such as Tai Chi Easy, can help reduce symptom severity, improve mental health, and decrease reliance on opioids, making them valuable components of OUD management.

How does Self-Determination Theory influence treatment outcomes? SDT emphasizes the importance of fulfilling individual psychological needs. By fostering autonomy, competence, and relatedness, it can enhance intrinsic motivation and improve treatment engagement for individuals with OUD.

What are the future directions for OUD research? Future research aims to refine holistic frameworks for OUD management, explore innovative treatment interventions, and develop prevention strategies to address the underlying causes of OUD.

References

1. Coffee, Z., Taylor-Piliae, R., Badger, T., Gordon, J., & Reed, P. (2025). A New Holistic Theoretical Framework to Inform Opioid Use Disorder Management. Journal of Addictions Nursing, 35(1), 1-8. doi:10.1097/JAN.0000000000000603

2. Ahmadi, Z., Smallwood, N. E., Russell, A.-M., Saggu, R., Romero, L., & Ekström, M. (2024). Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis. European Respiratory Review, 33(4), 1-10. doi:10.1183/16000617.0025-2024. Available from: https://pubmed.ncbi.nlm.nih.gov/11880903/

3. Nitsche, L. J. B., Devlin, P. J., Bond, S. J., Friedman, J. A., Rubnitz, K. R., Bontrager, C. E. B., & Karel, L. I. (2024). Use of bupivacaine liposomal injectable suspension in children aged 2 to 6 years undergoing cardiac surgery does not accelerate recovery. JTCVS Open. doi:10.1016/j.xjon.2024.11.013. Available from: https://doi.org/10.1016/j.xjon.2024.11.013

4. Liu, Y., Zhang, Y., & Li, H. (2025). Recent advances in the bench-to-bedside translation of cancer nanomedicines. Acta Pharm Sin B, 15(3), 1-12. doi:10.1016/j.apsb.2024.12.007. Available from: https://doi.org/10.1016/j.apsb.2024.12.007

5. Zhanette, C. (2025). Consumption of analgesics in American football, in the Federal State of Hesse, Germany: protocol of a cross-sectional study. BMJ Open. doi:10.1136/bmjopen-2024-093432. Available from: https://doi.org/10.1136/bmjopen-2024-093432